Ingredient

Sitagliptin Phosphate Hydrate

Sitagliptin phosphate monohydrate is a blood sugar control ingredient used in the treatment of type 2 diabetes.

See medicines used for Chronic Conditions
All medicines
245
Single ingredient
41
Combination
204
Prescription medication
245

MFDS ingredient code M251915

What does it do?

Sitagliptin phosphate monohydrate is a component of the DPP-4 inhibitor class of diabetes medications. It is used to lower blood sugar by promoting insulin secretion and inhibiting blood sugar increases.

Sitagliptin phosphate monohydrate inhibits the DPP-4 enzyme in the body, preventing the breakdown of incretin hormones. This results in increased insulin secretion and effective blood sugar control.

Commonly used for

Approved uses differ by product. Check each product's information for its actual use.

Good to know

Compared to other DPP-4 inhibitors, sitagliptin has a stable blood sugar control effect and fewer side effects. It can be used alone or in combination with other diabetes medications.

Medicines containing this ingredient

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Category
Dosage form
Strength
Category

245 total

View more

Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.

Combined ingredients

Ingredients used together with this ingredient in combination products.

Questions about this ingredient

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

SourceKorea Ministry of Food and Drug Safety (Drug Safety Korea)

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.